Man Group plc - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Man Group plc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$88,000
-54.6%
19,000
-38.6%
0.00%
-100.0%
Q3 2018$194,000
+104.2%
30,937
+163.0%
0.00%
Q2 2018$95,00011,7640.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders